exenatide
Generic: exenatide·Brand: Bydureon, Byetta
exenatide: 1 clinical trial tracked.
exenatide evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about exenatide, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
EXCEED - A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Primary endpoint: Incidence rate of primary diagnosis of pancreatic cancer among exenatide exposed population
Observational24,000 targetStarted 2024-09Completion 2026-108 sites · Denmark, Finland, France, Norway…AstraZeneca